Statistical performance of group sequential methods for observational post-licensure medical product safety surveillance: A simulation study

Statistics and its Interface

Volumn 5, Issue 4, 2012, Pages 381-390

  Zhao, Shanshan ^a   Cook, Andrea ^b   Jackson, Lisa ^b   Nelson, Jennifer ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Medical product safety; Observational study; Post licensure surveillance; Sequential testing

Indexed keywords

EID: 84872237903     PISSN: 19387989     EISSN: 19387997     Source Type: Journal    
DOI: 10.4310/sii.2012.v5.n4.a1     Document Type: Article

References (23)

1. Armitage, P., McPherson, C. K., and Rowe, B. C. (1969). Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A 132 235-244. MR0250405
2. Baggs, J., Gee, J., Fowler, G., Weintraub, E., Lewis, E., Klein, N. P., Baxter, R., Benson, P., Jackson, L., Lieu, T., Naleway, A., Belongia, E., Glanz, J., Hambidge, S. J., Jacobsen, S. J., and Nordin, J. (2011). The vaccine safety datalink: A model for monitoring immunization safety. Pediatrics 127 S45- S53.
3. Behrman, R. E., Benner, J. S., Brown, J. S., McClellan, M., Woodcock, J., and Platt, R. (2011). Developing the sentinel system-a national resource for evidence development. New England Journal of Medicine 364 498-499.
4. Belongia, E. A., Irving, S. A., Shui, I. M., Kulldorff, M., Lewis, E., Yin, R., Lieu, T. A., Weintraub, E., Yih, W. K., Li, R., Baggs, J., and Vaccine Safety Datalink Investigation Group (2010). Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 29 1-5.
5. Emerson, S. S. and Fleming, T. R. (1989). Symmetric group sequential test designs. Biometrics 45 905-923. MR1029609
6. Greene, S. K., Kulldorff, M., Lewis, E. M., Li, R., Yin, R., Weintraub, E. S., Fireman, B. H., Lieu, T. A., Nordin, J. D., Glanz, J. M., Baxter, R., Jacobsen, S. J., Broder, K. R., and Lee, G. M. (2010). Near real-time surveillance for influenza vaccine safety: Proof-of-concept in the vaccine safety datalink project. Am J Epidemiol 171 177-188.
7. Jennison, C. and Turnbull, B. W. (1993). Group sequential tests for bivariate response: Interim analyses of clinical trials with both efficacy and safety endpoints. Biometrics 49 741-752. MR1243490
8. Kittelson, J. M. and Emerson, S. S. (1999). A unifying family of group sequential test designs. Biometrics 55 874-882. MR1720716
9. Klein, N. P., Fireman, B., Yih, W. K., Lewis, E., Kulldorff, M., Ray, P., Baxter, R., Hambidge, S., Nordin, J., Naleway, A., Belongia, E. A., Lieu, T., Baggs, J., Weintraub, E., and Vaccine Safety Datalink (2010). Measlesmumps- rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126 1-8.
10. Kulldorff, M., Davis, R. L., Kolczak, M., Lewis, E., Lieu, T., and Platt, R. (2011). A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Analysis 30 58-78. MR2770706
11. Lai, T. L. and Shih, M.-C. (2004). Power, sample size and adaptation considerations in the design of group sequential clinical trials. Biometrika 91 507-528. MR2090619
12. Li, L. (2009). A conditional sequential sampling procedure for drug safety surveillance. Statistics in Medicine 28 3124-3138. MR2750410
13. Lieu, T. A., Kulldorff, M., Davis, R. L., Lewis, E. M., Weintraub, E., Yih, K., Yin, R., Brown, J. S., Platt, R., and for the Vaccine Safety Datalink Rapid Cycle Analysis Team (2007). Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 45 89-95.
14. Nelson, J. C., Cook, A. J., Yu, O., Zhao, S., Jackson, L. A., and Psaty, B. M. (2011). Methods for observational postlicensure medical product safety surveillance. Statistical Methods in Medical Research.
15. O'Brien, P. C. and Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics 35 549-556.
16. Pampallona, S. and Tsiatis, A. A. (1994). Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stoppong in favor of the null hypothesis. Journal of Statistical Planning and Inference 42 19-35. MR1309622
17. Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika 64 191-200.
18. Pocock, S. J. (1982). Interim analyses for randomized clinical trials: The group sequential approach. Biometrics 38 153-162.
19. Shih, M.-C., Lai, T. L., Heyse, J. F., and Chen, J. (2010). Developing the sentinel system - a national resource for evidence sequential generalized likelihood ratio tests for vaccine safety evaluation. Statistics in Medicine 29 2698-2708. MR2757017
20. Topol, E. J. (2004). Failing the public health - rofecoxib, merck, and the FDA. N Engl J Med 351 1707-1709.
21. United States Code (2008). US Public Law 110-85 Food and Drug Administration Amendments Act of 2007 Accessed January 6, 2010.
22. Wald, A. (1945). Sequential tests of statistical hypotheses. Annals of Mathematical Statistics 16 117-186. MR0013275
23. Yih, W. K., Nordin, J. D., Kulldorff, M., Lewis, E. M., Lieu, T. A., Shi, P., and Weintraub, E. (2009). An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the vaccine safety datalink. Vaccine 27(32) 4257-4262.s